Report Review: At-home diagnostics - a market boom waiting to happen
This article was originally published in Clinica
Executive Summary
Annual sales of at-home diagnostic products are set to reach $13.1bn by 2010, and are increasing at a rate of 8.8% a year. But for the market to really take off, companies need to develop a more united and "coherent market position". The industry's pace of development would increase if it built a stronger identity for itself.
You may also be interested in...
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.
Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire
Clarke helped launch GDUFA I and negotiate GDUFA II, chaired the CDER Executive Committee and oversaw many other programs in the US FDA’s drugs center.